NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

肢端肥大症(AC) - 流行病學的預測 ∼2027年

Acromegaly - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 524433
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
肢端肥大症(AC) - 流行病學的預測 ∼2027年 Acromegaly - Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的肢端肥大症(AC)的總患病數2016年估計為6萬610人。

本報告提供肢端肥大症(AC)的相關調查,疾病概要,患者背景,主要7個國家肢端肥大症(AC)的患病數、診斷數、可治療病例數預測(今後10年份),市場成長機會等資訊。

目錄

第1章 重要的洞察

第2章 疾病概要:肢端肥大症(AC)

  • 簡介
  • 徵兆與症狀
  • 下垂體腺瘤的分類
  • 肢端肥大症臨床症狀
  • 病因
  • 病理生理學
  • 肢端肥大症的遺傳性要素
  • 病因
  • 診斷
    • 診斷指南
    • 內分泌學會診療指南作成委員(英國)
    • 美國臨床內分泌學會(美國)

第3章 流行病學和患者人口

第4章 主要觀察

第5章 主要7個國家的流行病學

  • 主要7個國家肢端肥大症的總患病數
  • 主要7個國家肢端肥大症的患病數:各原因

第6章 美國的流行病學

  • 肢端肥大症(AC)的患病數
  • 肢端肥大症(AC)的患病數:各原因
  • 肢端肥大症(AC)的診斷數
  • 肢端肥大症(AC)的診斷數:各腺瘤
  • 肢端肥大症(AC)的可治療病例數

第7章 歐洲5個國家的流行病學

  • 英國
    • 肢端肥大症(AC)的患病數
    • 肢端肥大症(AC)的患病數:各原因
    • 肢端肥大症(AC)的診斷數
    • 肢端肥大症(AC)的診斷數:各腺瘤
    • 肢端肥大症(AC)的可治療病例數病例數
  • 德國
    • 肢端肥大症(AC)的患病數
    • 肢端肥大症(AC)的患病數:各原因
    • 肢端肥大症(AC)的診斷數
    • 肢端肥大症(AC)的診斷數:各腺瘤
    • 肢端肥大症(AC)的可治療病例數病例數
  • 法國
    • 肢端肥大症(AC)的患病數
    • 肢端肥大症(AC)的患病數:各原因
    • 肢端肥大症(AC)的診斷數
    • 肢端肥大症(AC)的診斷數:各腺瘤
    • 肢端肥大症(AC)的可治療病例數病例數
  • 義大利
    • 肢端肥大症(AC)的患病數
    • 肢端肥大症(AC)的患病數:各原因
    • 肢端肥大症(AC)的診斷數
    • 肢端肥大症(AC)的診斷數:各腺瘤
    • 肢端肥大症(AC)的可治療病例數病例數
  • 西班牙
    • 肢端肥大症(AC)的患病數
    • 肢端肥大症(AC)的患病數:各原因
    • 肢端肥大症(AC)的診斷數
    • 肢端肥大症(AC)的診斷數:各腺瘤
    • 肢端肥大症(AC)的可治療病例數病例數

第8章 日本的流行病學

  • 肢端肥大症(AC)的患病數
  • 肢端肥大症(AC)的患病數:各原因
  • 肢端肥大症(AC)的診斷數
  • 肢端肥大症(AC)的診斷數:各腺瘤
  • 肢端肥大症(AC)的可治療病例數病例數

第9章 未滿足需求

第10章 附錄

  • 調查方法

第11章 DelveInsight的服務內容

第12章 免責聲明

第13章 關於DelveInsight

目錄
Product Code: DIEI0017

DelveInsight's "Acromegaly - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Acromegaly epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Acromegaly Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Acromegaly in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Acromegaly outlook. It also includes the explanation of changing trends of epidemiology outlining the Acromegaly scenario.

Acromegaly Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Acromegaly thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Acromegaly explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Acromegaly Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Acromegaly

Key assessments

  • Patient Segmentation in Acromegaly
  • Acromegaly Risk & Burden
  • Factors driving growth in a specific Acromegaly patient population

Table of Contents

1. Report Introduction

2. Acromegaly Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Acromegaly in 2016
  • 2.2. Patient Share Distribution of Acromegaly in 2028

3. Disease Background and Overview: Acromegaly

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Acromegaly in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Acromegaly in 7MM - By Countries

5. Epidemiology of Acromegaly by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Acromegaly
    • 5.1.3. Sub-Type Specific cases of the Acromegaly *
    • 5.1.4. Sex- Specific Cases of the Acromegaly *
    • 5.1.5. Diagnosed Cases of the Acromegaly
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Acromegaly
    • 5.4.3. Sub-Type Specific cases of the Acromegaly *
    • 5.4.4. Sex- Specific Cases of the Acromegaly *
    • 5.4.5. Diagnosed Cases of the Acromegaly
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Acromegaly
    • 5.5.3. Sub-Type Specific cases of the Acromegaly *
    • 5.5.4. Sex- Specific Cases of the Acromegaly *
    • 5.5.5. Diagnosed Cases of the Acromegaly
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Acromegaly
    • 5.6.3. Sub-Type Specific cases of the Acromegaly *
    • 5.6.4. Sex- Specific Cases of the Acromegaly *
    • 5.6.5. Diagnosed Cases of the Acromegaly
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Acromegaly
    • 5.7.3. Sub-Type Specific cases of the Acromegaly *
    • 5.7.4. Sex- Specific Cases of the Acromegaly *
    • 5.7.5. Diagnosed Cases of the Acromegaly
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Acromegaly
    • 5.8.3. Sub-Type Specific cases of the Acromegaly *
    • 5.8.4. Sex- Specific Cases of the Acromegaly *
    • 5.8.5. Diagnosed Cases of the Acromegaly
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Acromegaly
    • 5.9.3. Sub-Type Specific cases of the Acromegaly *
    • 5.9.4. Sex- Specific Cases of the Acromegaly *
    • 5.9.5. Diagnosed Cases of the Acromegaly

6. Unmet Needs of the Acromegaly

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Acromegaly in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Acromegaly in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Acromegaly in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Acromegaly in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Acromegaly in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Acromegaly in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Acromegaly in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Acromegaly in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Acromegaly in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Acromegaly in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Acromegaly in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Acromegaly in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Acromegaly in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Acromegaly in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Acromegaly in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Acromegaly in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Acromegaly in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Acromegaly in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Acromegaly in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Acromegaly in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Acromegaly in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Acromegaly in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Acromegaly in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Acromegaly in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Acromegaly in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Acromegaly in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Acromegaly in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Acromegaly in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Acromegaly in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Acromegaly in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Acromegaly in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Acromegaly in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Acromegaly in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Acromegaly in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Acromegaly in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Acromegaly in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Acromegaly in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Acromegaly in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Acromegaly in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Acromegaly in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Acromegaly in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Acromegaly in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Acromegaly in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Acromegaly in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Acromegaly in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Acromegaly in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Acromegaly in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Acromegaly in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Acromegaly in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Acromegaly in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Acromegaly in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Acromegaly in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Acromegaly in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Acromegaly in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Acromegaly in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Acromegaly in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Acromegaly in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Acromegaly in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Acromegaly in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Acromegaly in Japan (2016-2028)